COVID drug combo trial tests new study design
Knowledge-focused
Completed
This completed Phase 2 trial aimed to test a master protocol that could be used to evaluate the safety and effectiveness of different drug combinations for COVID-19 patients. The study planned to enroll both hospitalized and non-hospitalized adults, but only 4 people took part. T…
Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Knowledge-focused
Last updated Apr 29, 2026 07:11 UTC